Rare disease

Osteosarcoma

Clinical trials recruiting in Australia for Osteosarcoma, a rare disease, as the public registries list them.

Also called: Osteogenic sarcoma; Osteosarcoma of bone

Sources: ClinicalTrials.gov, Orphanet Checked: 13 October 2026 Not medical advice

At a glance

4 trials recruiting in Australia

165 trials recruiting overseas

1-9 / 100 000 (Point prevalence, Europe, Validated) prevalence

Childhood age of onset

13 October 2026 date last checked

Trials in Australia

This Australian count is likely to be on the low side. It counts the trials this site files under this condition; the registry’s own search is broader and also returns closely related conditions, some of which have their own page here. If you are searching widely, check the registry as well — every trial below links to its own record.

  • Recruiting Not a phased study

    Study for people with Osteosarcoma

    Where
    • Princess Margaret Hospital for Children, Perth (WA) — Active not recruiting
    • Perth Children's Hospital, Perth (WA) — Recruiting
    Who can join Age child, adult, older adult. Sex Anyone, regardless of sex. Healthy volunteers Not accepted.
    Sponsor Children's Oncology Group
    Timeline
    Started 5 March 2014 Today 16 October 2026 Estimated completion 31 December 2022

    Past estimated completion. The registry still lists this trial as open, and the date it gave for finishing has been and gone. Confirm with the official record before you act on it.

    NCT01790152 · Checked 11 October 2026

  • Recruiting Phase 3

    Phase 3 study for people with Osteosarcoma

    Where

    No Australian site on this record is listed as recruiting right now, even though the trial itself is open. Check with the site or the official record before travelling.

    • The Children's Hospital at Westmead, Westmead (NSW) — Suspended
    • Royal Children's Hospital, Parkville (VIC) — Suspended
    • Perth Children's Hospital, Perth (WA) — Suspended
    Who can join Age Up to 50 Years. Sex Anyone, regardless of sex. Healthy volunteers Not accepted.
    Sponsor Children's Oncology Group
    Timeline
    Started 1 April 2022 Today 16 October 2026 Estimated completion 31 March 2031

    NCT05235165 · Checked 11 October 2026

  • Recruiting Phase 2

    Phase 2 study for people with Osteosarcoma

    Where
    • Sydney Children's Hospital ( Site 1997), Randwick (NSW) — Recruiting
    • Queensland Children's Hospital-Oncology & Haematology ( Site 1996), Brisbane (QLD) — Recruiting
    • Royal Children's Hospital-Children's Cancer Centre ( Site 1994), Melbourne (VIC) — Recruiting
    Who can join Age 6 Months to 25 Years. Sex Anyone, regardless of sex. Healthy volunteers Not accepted.
    Sponsor Merck Sharp & Dohme LLC
    Timeline
    Started 16 August 2024 Today 16 October 2026 Estimated completion 31 March 2029

    NCT06395103 · Checked 13 October 2026

  • Recruiting Phase 1

    Phase 1 study for people with Osteosarcoma

    Where
    • Chris OBrien Lifehouse, Camperdown (NSW) — Recruiting
    • Peter MacCallum Cancer Centre, Melbourne (VIC) — Recruiting
    • Perth Childrens Hospital, Nedlands (WA) — Recruiting
    Who can join Age 2 Years and over. Sex Anyone, regardless of sex. Healthy volunteers Not accepted.
    Sponsor Amgen
    Timeline
    Started 8 April 2026 Today 16 October 2026 Estimated completion 26 May 2030

    NCT07297979 · Checked 11 October 2026

Trials overseas

165 trials for this disease are open to new participants outside Australia, as ClinicalTrials.gov listed them on 11 October 2026. Voxsanity does not publish a page for any of them; the searches below reach them at the registry.

These overseas counts are likely too high. They come from the registry’s own search, which expands a condition name to related conditions, so some of the trials counted are for a different disease in the same family.

Trials not shown here

Some Australian trials are registered only on the Australian New Zealand Clinical Trials Registry and are not shown here. Search them at Australian Clinical Trials.

Key facts

Inheritance Not applicable
Genes RB1, CHEK2, TP53, TP53
Prevalence 1-9 / 100 000 (Point prevalence, Europe, Validated)
Age of onset Childhood

Orphadata Science: Free access data from Orphanet. © INSERM 1999. Available on https://www.orphadata.com. Used under CC BY 4.0. Source: Orphanet / Orphadata (orphadata.com).

Sources and dates

  • ClinicalTrials.gov – trial records, statuses and site lists
  • Orphanet / Orphadata – prevalence, age of onset, inheritance, genes and alternative names, used under CC BY 4.0
  • ClinicalTrials.gov processing date: 6 October 2026.
  • This page last checked by Voxsanity: 13 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Orphanet citation

Orphadata Science: Free access data from Orphanet. © INSERM 1999. Available on https://www.orphadata.com. Used under CC BY 4.0. Source: Orphanet / Orphadata (orphadata.com). Accessed 20 September 2026.

ORPHA:668

Tell us which conditions matter to you

We use requests to help decide what to add next. Telling us about a condition is not a promise that we will add it, and we cannot say when any condition might appear.